Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Pernix Therapeutics Holdings- Inc. (PTX)

2.52 0.03 (1.2%)

06-19 11:49

Open:

2.5

Pre. Close:

2.49

High:

2.5301

Low:

2.42

Volume:

30,031

Market Cap:

30M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.503 - 2.513

2.513 - 2.521

Low:

2.383 - 2.395

2.395 - 2.405

Close:

2.469 - 2.489

2.489 - 2.506

Technical analysis  (as of: 2018-06-19 11:31:55 AM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 3.16     One year: 3.45

Support:

Support1: 2.31    Support2: 1.92

Resistance:

Resistance1: 2.71    Resistance2: 2.95

Pivot:

2.38

Moving Averages:

MA(5): 2.44     MA(20): 2.40

MA(100): 2.47     MA(250): 2.79

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.02

%K %D:

%K(14,3): 75.69     %D(3): 75.81

RSI:

RSI(14): 49.04

52-Week:

High: 5.18  Low: 2  Change(%): -44.1

Average Vol(K):

3-Month: 6502  10-Days 3750

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
PTX has closed below upper band by 30.7%. Bollinger Bands are 57.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to PTX's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-16T16:44:42-04:00
FDA OKs first non-opioid treatment for opioid withdrawal

2018-05-10T18:26:06-04:00
Pernix Therapeutics' (PTX) CEO John Sedor on Q1 2018 Results - Earnings Call Transcript

2018-05-10T16:05:01-04:00
Pernix Therapeutics reports Q1 results

2018-04-26T11:08:50-04:00
Pending Orexigen Sale Should Serve As Warning Sign

2018-04-26T03:18:20-04:00
Opioid prescriptions dropped 12% in 2017

2018-04-23T13:36:04-04:00
Orexigen agrees to sell itself to Nalpropion Pharma for $75M; shares down 34%

2018-04-19T11:25:01-04:00
U.S. opioid prescriptions down 12% last year, largest drop in 25 years

2018-04-17T15:35:03-04:00
DEA aiming to collar production of opioids

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

11.87

Shares Float (M)

2.81

% Held by Insiders

% Held by Institutions

16.50

Shares Short (K)

2157

Shares Short Prior Month (K)

101

Stock Financials

EPS

EPS Est. Current Year

-3.700

EPS Est. Next Year

0.100

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

5.790

PEG Ratio

Profit Margin

-45.63

Operating Margin

-33.04

Return on Assets (ttm)

-27.7

Return on Equity (ttm)

37.0

Qtrly Rev. Growth

37.7

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-5.94

Levered Free Cash Flow (M)

29.14

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

0.42

P/S

2105967.75

P/CF

-4.84

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

2001-08-21

Forward Dividend

Last Split Date

2016-10-14

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.